Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/inaugural-croucher-professorship-in-medical-science-lecture-by-professor-siew-ng-a-magical-pursuit
https://www.med.cuhk.edu.hk/press-releases/inaugural-croucher-professorship-in-medical-science-lecture-by-professor-siew-ng-a-magical-pursuit

Inaugural Croucher Professorship in Medical Sciences lecture by Professor Siew Ng: A Magical Pursuit

Croucher Professorship

Professor Siew Ng from the Department of Medicine and Therapeutics at CU Medicine is named the Croucher Professor in Medical Sciences, the very first named professorship bestowed in the name of Croucher Foundation. (From right) Professor Siew Ng, Professor of the Department of Medicine and Therapeutics at CU Medicine; Professor Rocky Tuan, Vice-Chancellor and President of CUHK; Professor Timothy Cox, Chairman of the Croucher Foundation; and Professor Francis Chan, Dean of CU Medicine. 

Professor Siew Ng from the Department of Medicine and Therapeutics at The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) has been named the Croucher Professor in Medical Sciences, the very first named professorship bestowed in the name of Croucher Foundation. In the inaugural lecture, Professor Ng, a world-renowned clinician-scientist studying the gut microbiome, shared her life journey as a scientist and an entrepreneur, and the highs and lows in her pursuit of her dream as a “microbe hunter".

                                                     

Establishing Asia’s first microbiota transplantation and research centre

 

The human gut is like our second brain. We each have more microbe genes in bodies than our own genes. Over the past decade, Professor Ng has shown that the gut microbiome is closely related to a number of common human diseases. She and her team have transformed her research findings into non-invasive diagnostic tools and microbiome therapeutics.

 

Professor Ng first became intrigued with the germs in the gut during her PhD studies at Imperial College London 10 years ago. She joined CU Medicine in 2010 and started studying a chronic gut disease, inflammatory bowel disease (IBD), which was growing in Asia. She and her team were the first to define the burden of IBD in Asia. She showed that the number of IBD cases had surged by 30 times in Hong Kong in three decades. She also discovered that this increase is due to changes in lifestyle and diet impacting the human gut microbiome. In 2013, she introduced faecal microbiota transplantation in Hong Kong to treat patients with a life-threatening intestinal infections. In 2018, she established Asia’s first microbiota transplantation (FMT) and research centre, which now serves as the sole provider of FMT services to all 40 hospitals run by the Hospital Authority in Hong Kong. In 2019, she established the Microbiota I-Center (MagIC) under the HKSAR Government’s InnoHK initiative and co-founded a biotechnology company that focuses on translating innovative microbiome solutions into effective diagnostics and therapeutics.   

 

Professor Siew Ng

At the inaugural lecture Professor Siew Ng shares her life journey as a clinician, a scientist and an entrepreneur, and the highs and lows in her pursuit of her dream as a “microbe hunter".

Professor Ng said, “We have only begun to unleash the potential power of our gut microbes. Science is proving that an imbalanced gut microbiome can trigger many different health problems. We have identified novel bacteria signatures in the stool that can accurately detect colon cancer, IBD, autism and long COVID-19 early, when treatment or cure is possible. I would like to express my heartfelt gratitude to the Croucher Foundation for granting me the Croucher Senior Medical Research Fellowships in 2020 to further my research on IBD. I am very honoured and humbled to be the first recipient of the Croucher Professorship in Medical Science. It marks an important milestone in my academic and research career. The path to discovery is long but it is important to leave no stone unturned if we want to make important discoveries. I plan to dedicate myself to medical research and to contribute to the improvement of people’s health in Hong Kong and beyond.”

Siew Ng’s Journey from Malaysia to the United Kingdom to Hong Kong

 

Professor Ng has been fascinated by the human body since she was a child. Born in Penang, Malaysia, she went to the United Kingdom to study medicine and completed a PhD in 2009. In 2010, she moved to Hong Kong and joined CU Medicine. She said, “I am fortunate to have had many opportunities in my life and to wear multiple hats at the same time: a clinician, a scientist, a mentor and an entrepreneur. Coming to Hong Kong is like a dream come true. The city has a pool of world-renowned scientists and clinicians, an inspiring research environment and an innovative culture which provides a fertile environment for me to explore. This is a golden time to pursue a research career in Hong Kong.”  

 

In 2019, Professor Ng co-founded her own biotechnology company, Geniebiome, which focuses on providing microbiome diagnostic tests and treatment. She said, “Setting up my own venture, as opposed to licensing my discoveries to other parties, has enabled me to maximise the benefits of my research for the development of Hong Kong’s innovation and technology industry. This is just the beginning: we will continue to crack the microbiome Da Vinci Code for various human diseases.”

 

Croucher Foundation Board of Trustees

 A group photo of Professor Rocky Tuan (centre), Professor Francis Chan (3rd from left) and Professor Siew Ng (4th from right) with the Board of Trustees of the Croucher Foundation. 

Visit to research lab

The Board of Trustees of the Croucher Foundation visits the research laboratory of Professor Ng.

Professor Ng is currently the Assistant Dean (Development) of CU Medicine; Professor, Department of Medicine and Therapeutics; Associate Director of the Centre for Gut Microbiota Research; and Director of the Microbiota I-Center (MagIC). She has published more than 320 peer-reviewed papers in international journals, including The Lancet, Nature Genetics and Cell Host & Microbe. Her research has received numerous awards, including the 2017 Sir David Todd Lectureship and 2020 Ministry of Education Higher Education Outstanding Scientific Research Output Award. She was named a Highly-cited Researcher by Clarivate for three consecutive years, from 2020 to 2022. Recently she received the Higher Flyer Innopreneur Award and the Most Popular Innopreneur Award from the Federation of Hong Kong Industries.

 

Professor Timothy Cox

Professor Timothy Cox says CUHK is a major academic partner of the Croucher Foundation and that the establishment of the new Professorship strengthens the tie with its Faculty of Medicine. The two share a common vision to promote scientific excellence to the benefit of the whole community. 

token of thanks

Professor Rocky Tuan delivers a token of thanks to Professor Cox. 

About the Croucher Professorship in Medical Science

 

The Croucher Foundation was established by the late Noel Croucher in 1979. After a long, successful career in Hong Kong, Mr Croucher took the momentous decision to give away his entire life’s fortune to support science, technology and medicine. By keeping a sharp focus on the promotion of scientific excellence, he expected that Hong Kong would gradually gain recognition as a world-class centre for education and research, to the benefit of the whole community. The Foundation is delighted that through this endowment, Mr Croucher’s inestimable contribution to Hong Kong science can be recognised.

More Press Releases

CU Medicine invents a non-invasive technology for people with uninvestigated bowel symptoms

CU Medicine invents a non-invasive technology for people with uninvestigated bowel symptoms

Research
CU Medicine’s large-scale mother-baby study finds altered gut microbiome  in pregnant mothers with gestational diabetes mellitus affects infants’ neurodevelopment

CU Medicine’s large-scale mother-baby study finds altered gut microbiome in pregnant mothers with gestational diabetes mellitus affects infants’ neurodevelopment

Research
CUHK identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders  Pilot clinical study shows modulation of gut microbiome alleviates anxiety symptoms

CUHK identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders Pilot clinical study shows modulation of gut microbiome alleviates anxiety symptoms

Research
CUHK Professor Siew Ng is the first female clinician-scientist in mainland China selected as a New Cornerstone Investigator; New Cornerstone Science Laboratory inaugurated to dissect diet-microbiome interactions to improve human health

CUHK Professor Siew Ng is the first female clinician-scientist in mainland China selected as a New Cornerstone Investigator; New Cornerstone Science Laboratory inaugurated to dissect diet-microbiome interactions to improve human health

Awards and honors
Two CU Medicine scholars are elected as Foreign Members of the Academia Europaea

Two CU Medicine scholars are elected as Foreign Members of the Academia Europaea

Awards and honors
CUHK Professor Siew Ng becomes the first clinician-scientist in Hong Kong  to be selected as a New Cornerstone Investigator

CUHK Professor Siew Ng becomes the first clinician-scientist in Hong Kong to be selected as a New Cornerstone Investigator

Awards and honors
A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

Research
CU Medicine leads new clinical practice guidelines on use of non-invasive biomarkers for colorectal cancer screening with international experts

CU Medicine leads new clinical practice guidelines on use of non-invasive biomarkers for colorectal cancer screening with international experts

Research
CU Medicine’s population-based long COVID-19 survey estimates that over 400,000 recovered COVID-19 patients suffer from sexual dysfunction and reproductive problems

CU Medicine’s population-based long COVID-19 survey estimates that over 400,000 recovered COVID-19 patients suffer from sexual dysfunction and reproductive problems

Research
CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

Research
CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

Research
CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers  with Sensitivity Over 90%

CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers with Sensitivity Over 90%

Research
CU Medicine Study Suggests Toddlers are at High Risk of Being  “Silent Spreaders of SARS-CoV2 Infection”

CU Medicine Study Suggests Toddlers are at High Risk of Being “Silent Spreaders of SARS-CoV2 Infection”

Research
CU Medicine Study Shows Modulation of Gut Microbiota  Helps Enhance Safety and Efficacy of COVID-19 Vaccine

CU Medicine Study Shows Modulation of Gut Microbiota Helps Enhance Safety and Efficacy of COVID-19 Vaccine

Research
CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

Research
CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

Research
40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

Research
CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

Research
CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

Research
The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

Research
Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Awards and honors
CUHK Establishes Asia’s First Microbiota Transplantation and Research Centre Hope for New Strategies in Disease Prevention and Cure

CUHK Establishes Asia’s First Microbiota Transplantation and Research Centre Hope for New Strategies in Disease Prevention and Cure

Research
CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

Research
CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

Research
CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

Research
CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

Research
CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

Research
Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.